Clinical trial
Treatment for Chronic Pain in Patients With Advanced Cancer
NCT00003687 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003687 |
|---|---|
| Title | Treatment for Chronic Pain in Patients With Advanced Cancer |
| Official title | A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Pain, Precancerous/Nonmalignant Condition, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | dextromethorphan hydrobromide, morphine sulfate |
| Enrollment | 87 |
| Start date | Jun 11, 1998 |
| Primary completion | Sep 26, 2001 |
| Completion | Feb 10, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: